Vetmedin-CA1 Chewable Tablets

Vetmedin®-CA1 Chewable Tablets

Vetmedin®-CA1 is indicated for the delay onset of congestive heart failure in dogs with stage B2 preclinical myxomatous mitral valve disease (MMVD).  This medication is for dogs in pre-clinical stage B2 (asymptomatic MMVD with a moderate or loud mitral murmur due to mitral regurgitation and evidence of increased heart size) to delay the onset of clinical signs of heart failure. 

Dogs

Pimobendan

Vetmedin®-CA1

Inodilator

Vetmedin®-CA1 Chewable Tablets are artificial beef flavored.

Boehringer Ingelheim

Vetmedin®-CA1 1.25 mg Chewable Tablets:  16 mm, brown, oval tablet, scored in half, no imprint. (NDC 00010-4610-01)

Vetmedin®-CA1 5 mg Chewable Tablets: 23 mm, brown, oval tablet, scored in half, no imprint. (NDC 00010-4612-01)

Pimobendan

Vetmedin®-CA1 should be given orally as directed by your veterinarian.

Give the dose as soon as possible. If it is almost time for the next dose, skip the missed dose, and continue with the regular schedule. Do not give the pet two doses at once. Contact your veterinarian if you miss giving doses for two or more days in a row.

Side effects may include vomiting, diarrhea, lack of appetite, pain, lameness, arthritis, urinary tract infections, and seizure. Contact your veterinarian if these adverse effects occur.

Other side effects may occur. If you notice anything unusual, contact your veterinarian.

The following list of medicines may potentially interact with pimobendan: other positive inotropes and drugs that are highly protein bound. Concurrent use of beta-blockers or calcium channel blockers may decrease the effects of pimobendan. Contact your veterinarian if your pet experiences any unusual reactions when different medications are given together.

Make sure to tell your veterinarian what other medication or supplements you are giving to your pet. Quite often your veterinarian may prescribe two different medications, even if a drug interaction may be anticipated. In this case, your veterinarian may vary the dose and/or monitor your pet more closely.

Keep Vetmedin in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose. Not for use in humans.

Vetmedin®-CA1 Chewable Tablets is only approved for use in dogs diagnosed with myxomatous mitral valve disease (MMVD) at a stage known as B2 (asymptomatic with a murmur and evidence of increased heart size).

Allergic reactions to medications may occur. Be sure to inform VetSource and your veterinarian if your pet has any known drug sensitivities or allergies. If your pet displays symptoms of an allergic reaction, call your veterinarian immediately or go to a veterinary emergency clinic. Symptoms may include but are not limited to: swollen lips, tongue, face, airways; difficulty breathing; agitation; profuse salivation; vomiting; widespread hives and itching.

If you are concerned that your pet has experienced an adverse reaction to this medication or you have concerns about the product, please contact the manufacturer Boehringer Ingelheim at 888-637-4251 or contact Vetsource customer service at 877-738-4443.

Store long term at 68°F to 77°F in controlled room temperature, excursion permitted between 59°F to 86°F. Store in original packaging to protect from light.  Keep out of reach of children and pets. Store in a childproof container. Store this medicine in a cool, dry place at room temperature. Store away from heat and direct sunlight. Do not store this medicine in the bathroom, near the kitchen sink or in damp places. The medicine may break down if exposed to heat or moisture.